Skip to content

Impact of Intermittent Fasting and Mediterranean Diet on the Physical Health of the Elderly

Impact of Intermittent Fasting and Mediterranean Diet on the Physical Health of the Elderly: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06480669
Acronym
FASTMED
Enrollment
17
Registered
2024-06-28
Start date
2024-01-01
Completion date
2024-06-04
Last updated
2024-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Dyslipidemias, Hypertension, Obesity

Brief summary

The prevalence of chronic diseases is increasing globally. In recent years, intermittent fasting has emerged as an effective dietary pattern against some of the most common chronic diseases in the elderly, alongside the Mediterranean diet. The objective was to determine whether a 12-hour daily intermittent fasting regimen combined with a Mediterranean diet can improve analytical and anthropometric values in the elderly. A total of 17 individuals of both sexes, over 60 years old, autonomous, and with preserved cognitive capacity participated. They were randomly divided into two groups: 8 people in the intervention group performed intermittent fasting along with a Mediterranean diet, and 9 in the control group adopted only a Mediterranean diet. The intervention lasted 3 months, with measurements taken at the beginning and end of the intervention.

Interventions

OTHERTime Restricted Feeding

8 participants who practiced a 12/12 TRF (12 hours of fasting, from approximately 20:30 to 8:30 the following day).

OTHERMediterranean Diet

A control group consisting of 9 participants who followed a standard Mediterranean diet.

Sponsors

Universidad de Zaragoza
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
61 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Over 60 years of age. * Belong to the Bombarda health centre. * Preserved cognitive capacity. * Autonomy for basic and instrumental activities of daily living. * Ability to follow a TRF and/or adopt a Mediterranean dietary pattern.

Exclusion criteria

* Underweight (BMI \<18.5). * Serious or chronic uncontrolled disease. * Specific treatment that could alter blood and/or anthropometric values. * Poorly controlled type 1 or type 2 insulin-dependent diabetes mellitus. * Present or past episode of eating disorder (ED). * High alcohol consumption.

Design outcomes

Primary

MeasureTime frameDescription
Biochemical values (mg/dL)12 weeksBasal glucose, High-Density Lipoprotein, Low-Density Lipoprotein, total cholesterol, triglycerides, serum transferrin, urea, uric acid, creatinine.
Blood Pressure (mmHg)12 weeksBlood pressure (Systolic blood pressure, diastolic blood pressure)
Anthropometric values (kg)12 weeksWeight
Anthropometric values (cm)12 weeksWeight, waist circumference, hip circumference.
Anthropometric values (kg/m^2)12 weeksBody mass index.
Anthropometric index (numerical rating scale)12 weeksAtherogenic index of plasma, waist/hip ratio.
Biochemical values (IU/L)12 weeksAlkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, gamma-glutamyltransferase
Biochemical values (mg/L)12 weeksC-Reactive Protein
Biochemical values (µg/L)12 weeksSerum ferritin
Biochemical values (µg/dL)12 weeksIron
Biochemical values (g/dL)12 weeksAlbumin

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026